Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Oxidative Medicine and Cellular Longevity|May 29, 2014
Lentivirus-mediated Nox4 shRNA invasion and angiogenesis and enhances radiosensitivity in human glioblastomaYongsheng Li, Na Han, Tiejun Yin, et al.
Oncology Reports|November 12, 2014
DJ-1 knockdown inhibits growth and xenograft‑induced tumor generation of human hepatocellular carcinoma cellsShunfang Liu, Guoxian Long, Honglan Wei, et al.
Journal of Medicinal Chemistry|December 17, 2025
Ferroptosis/Apoptosis Induction by an Iridium Complex Encapsulated in PLGA Nanoparticles Enhances Efficacy and Reduces Toxicity in Breast CancerShunfang Liu, Wenhao Wu, Linrong Fang, et al.
Cancer Cell International|February 19, 2021
Ring finger protein 152-dependent degradation of TSPAN12 suppresses hepatocellular carcinoma progressionJian Wan, Shunfang Liu, Wanju Sun, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 7, 2017
Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2Guopeng Zhang, Dongbo Liu, Guoxian Long, et al.
Oxidative Medicine and Cellular Longevity|June 30, 2022
DJ-1/FGFR-1 Signaling Pathway Contributes to Sorafenib Resistance in Hepatocellular CarcinomaXin Chen, Guohua Yang, Xiaohong Guo, et al.
Biochemical and Biophysical Research Communications|October 14, 2025
Integrative multi-omics analysis uncovers a novel FOSL2-COL8A1-EMT regulatory axis driving colorectal cancer progressionXingyu Zhang, Teng Yu, Xiuming Li, et al.
Frontiers in Medicine|November 30, 2020
Absolute Eosinophil Count Predicts Intensive Care Unit Transfer Among Elderly COVID-19 Patients From General Isolation WardsJinjin Huang, Zhicheng Zhang, Shunfang Liu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 14, 2025
FBXW8-mediated degradation of PPT1 suppresses epithelial-mesenchymal transition and metastasis in hepatocellular carcinomaJingliang He, Xun Zou, Dan Wang, et al.
Oncology Reports|May 17, 2018
Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiencyLin Yang, Guanghai Yang, Yingjun Ding, et al.
Pageof 4